Replicel
Collapse
X
-
Comment
-
It's very good, just like it's great that Histogen is moving well down their strategic roadmap with other applications.
It means the product is working and the company has higher odds of raising more funds to launch the hair loss products.
Everyone's so hard on Replicel but they are here and working on their phase 2 so I don't understand why everyone is so upset.
Call me overoptimistic but with all these different research efforts undergoing around the world we will definitely have something very cosmetically satisfying in the medium run (maybe not the ultimate solution but a very good mix of them).
I say work hard and save money because when the day comes we'd better have 20K on us...Comment
-
no joke it's time to earn some money and save - the worst thing that could happen is having finally a cure and not being able to afford itComment
-
Alot of guys are waiting for 'the' cure but how many of us could really afford it, if the cure (from whomever it may be) came out tomorrow?
Cure's don't come cheap!Comment
-
Nothing else matters when you're bald. Big house, fancy car..nothing! None of it is worth it without follicles on my head.Comment
-
I'd downsize my home and make the necessary adjustments financially if it meant a full head of hair. That's how much it means to me. Cost wouldn't stop me if it was a sure fire cure.
Nothing else matters when you're bald. Big house, fancy car..nothing! None of it is worth it without follicles on my head.Comment
-
Quoted from Replicel's Investor Fact Sheet:
"Marketing And Sales Strategy
The RepliCel™ procedure will be internationally marketed to
medical professionals currently engaged in hair transplant
surgery and similar hair restoration programs, as well as
established hair loss and dermatology clinics. The procedure
will be offered via licensing agreements which will deliver two
streams of revenue to the company:
1. Procedure Access & Training (PAT) fees: An annual charge to
clinics for training and access to the RepliCel™ procedure.
2. Biopsy & Cell Replication (BCR) fees: A per-patient charge to
clinics and professionals for each procedure undertaken by
RepliCel approved laboratories."
As I look at the Replicel website's "Product Pipeline" under RCH-01-Hair, it looks as if Replicel, according to the black arrow in the graphic after "License", has already sold one of these "licencing agreements" to grow hair. That'd be a very good sign if someone actually bought one of these licensing agreements, wouldn't it?... if that's what it all means.Comment
-
-
Comment
Comment